✦ LIBER ✦
Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation
✍ Scribed by Marie-Magdelaine Coude; Odile Luycx; Marie-Estelle Cariou; Odile Maarek; Hervé Dombret; Jean-Michel Cayuela; Delphine Rea
- Book ID
- 114714615
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 164 KB
- Volume
- 157
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.